Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s00281-014-0436-6
Title: | The immunopathology of ANCA-associated vasculitis | Authors: | McKinney, E.F Willcocks, L.C Broecker, V Smith, K.G.C |
Keywords: | complement component C5a cyclophosphamide enzyme antibody immunosuppressive agent lysosome associated membrane protein 2 myeloblastin myeloperoxidase antibody neutrophil cytoplasmic antibody rituximab T lymphocyte receptor unclassified drug neutrophil cytoplasmic antibody ANCA associated vasculitis antibody titer antigen antibody reaction CD4+ T lymphocyte CD8+ T lymphocyte clinical feature complement system copy number variation disease classification genetic association genetic risk histopathology human immunopathology immunosuppressive treatment in vivo study lymphocyte function lymphocytic infiltration major histocompatibility complex nonhuman prevalence priority journal relapse review single nucleotide polymorphism treatment outcome Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis classification immunology pathology syndrome Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Antibodies, Antineutrophil Cytoplasmic Humans Syndrome |
Issue Date: | 2014 | Citation: | McKinney, E.F, Willcocks, L.C, Broecker, V, Smith, K.G.C (2014). The immunopathology of ANCA-associated vasculitis. Seminars in Immunopathology 36 (4) : 461-478. ScholarBank@NUS Repository. https://doi.org/10.1007/s00281-014-0436-6 | Rights: | Attribution 4.0 International | Abstract: | The small-vessel vasculitides are a group of disorders characterised by variable patterns of small blood vessel inflammation producing a markedly heterogeneous clinical phenotype. While any vessel in any organ may be involved, distinct but often overlapping sets of clinical features have allowed the description of three subtypes associated with the presence of circulating anti-neutrophil cytoplasmic antibodies (ANCA), namely granulomatosis with polyangiitis (GPA, formerly known as Wegener's Granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (eGPA, formerly known as Churg-Strauss syndrome). Together, these conditions are called the ANCA-associated vasculitidies (AAV). Both formal nomenclature and classification criteria for the syndromes have changed repeatedly since their description over 100 years ago and may conceivably do so again following recent reports showing distinct genetic associations of patients with detectable ANCA of distinct specificities. ANCA are not only useful in classifying the syndromes but substantial evidence implicates them in driving disease pathogenesis although the mechanism by which they develop and tolerance is broken remains controversial. Advances in our understanding of the pathogenesis of the syndromes have been accompanied by some progress in treatment, although much remains to be done to improve the chronic morbidity associated with the immunosuppression required for disease control. © 2014 The Author(s). | Source Title: | Seminars in Immunopathology | URI: | https://scholarbank.nus.edu.sg/handle/10635/181779 | ISSN: | 18632297 | DOI: | 10.1007/s00281-014-0436-6 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1007_s00281-014-0436-6.pdf | 1.13 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License